Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/20331
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ege, CB | - |
dc.contributor.author | Akbulut, Metin | - |
dc.contributor.author | Zekioglu, O | - |
dc.contributor.author | Ozdemir, N | - |
dc.date.accessioned | 2019-08-19T13:43:24Z | |
dc.date.available | 2019-08-19T13:43:24Z | |
dc.date.issued | 2011 | - |
dc.identifier.issn | 0932-0067 | - |
dc.identifier.uri | https://hdl.handle.net/11499/20331 | - |
dc.identifier.uri | https://doi.org/10.1007/s00404-010-1766-9 | - |
dc.description.abstract | Inhibitors of tumor angiogenesis and metastasis are emerging as important new drug candidates for cancer therapy. Galectin-3 and heparanase have been shown to function in tumor progression and metastatic spread. Both of them exert pleiotropic effects; proliferation, cell migration, differentiation and tissue remodeling. The aim of this study was to investigate heparanase and galectin-3 expression in endometrioid and serous carcinomas of the endometrium and their relation with well-known prognostic factors, in addition to estrogen, progesterone, C-erbB-2, Ki-67 and p53. | en_US |
dc.description.abstract | Sixty-four endometrial cancers, which include 24 serous types, were obtained from previously untreated patients. Immunohistochemical analysis of 64 carcinomas, 20 endometrial hyperplasia (ten of simple hyperplasia and ten of complex atypic hyperplasia) and 20 normal endometrium (ten of proliferative and ten of secretory) was performed. | en_US |
dc.description.abstract | This investigation suggests that the decreased expression of galectin-3 may be involved in the pathogenesis of endometrial carcinomas from normal endometrium to carcinoma. Also down-regulated stromal expression of galectin-3 in endometrial carcinoma may be involved in lymph node metastasis. Further studies on a larger advanced stage (FIGO stage 3-4) endometrial carcinoma group may determine the value of heparanase in the endometrial carcinoma. | en_US |
dc.language.iso | en | en_US |
dc.publisher | SPRINGER HEIDELBERG | en_US |
dc.relation.ispartof | ARCHIVES OF GYNECOLOGY AND OBSTETRICS | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Galectin-3; Heparanase; Serous endometrial carcinoma; Endometrial | en_US |
dc.subject | hyperplasia | en_US |
dc.title | Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 284 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 1231 | |
dc.identifier.startpage | 1231 | en_US |
dc.identifier.endpage | 1239 | en_US |
dc.identifier.doi | 10.1007/s00404-010-1766-9 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 21153652 | en_US |
dc.identifier.wos | WOS:000295737300026 | en_US |
dc.identifier.scopusquality | Q2 | - |
dc.owner | Pamukkale University | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
13
checked on Sep 30, 2024
WEB OF SCIENCETM
Citations
13
checked on Sep 30, 2024
Page view(s)
46
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.